55513-0520 Kepivance - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

55513-0520

Brand Name:

Kepivance

Generic Name:

Palifermin

Dosage Form Name:

Injection

Administration Route:

Substances:

Packages:

Code: 55513-0520-01

Description:

Effective Date: Dec. 15, 2004

Discontinued: Dec. 15, 2009

Code: 55513-0520-06

Description:

Effective Date: Dec. 15, 2004

Discontinued: Dec. 15, 2009

SEER*Rx Category:

Ancillary Therapy

Major Class:

Epithelial Growth Factor

Minor Class:

Keratinocyte Growth Factor/rHuKGF

Orphan Drug Designation:

Status:

No Longer Used